Non-invasive prenatal testing for single gene disorders: Exploring the ethics

European Journal of Human Genetics

Volumn 21, Issue 7, 2013, Pages 713-718

  Deans, Zuzana ^a   Hill, Melissa ^b   Chitty, Lyn S ^b   Lewis, Celine ^c  

^a UNIVERSITY OF BRISTOL   (United Kingdom)

^b UNIVERSITY COLLEGE LONDON   (United Kingdom)

^c GENETIC ALLIANCE UK   (United Kingdom)

Author keywords

cell free fetal DNA; ethics; non invasive prenatal diagnosis; single gene disorders

Indexed keywords

ARTICLE; FEMALE; FUNDING; GENETIC DISORDER; HELP SEEKING BEHAVIOR; HUMAN; MEDICAL DECISION MAKING; MEDICAL ETHICS; NON INVASIVE PROCEDURE; PATIENT AUTONOMY; PATIENT RIGHT; PATIENT SAFETY; PRENATAL DIAGNOSIS; PRIORITY JOURNAL; PRIVACY;

FEMALE; GENETIC DISEASES, INBORN; GENETIC TESTING; HUMANS; PREGNANCY; PRENATAL DIAGNOSIS;

EID: 84879421774     PISSN: 10184813     EISSN: 14765438     Source Type: Journal    
DOI: 10.1038/ejhg.2012.250     Document Type: Article

References (65)

1. Newson AJ: Ethical aspects arising from non-invasive fetal diagnosis. Semin Fetal Neonatal Med 2008; 13: 103-108.
2. Benn PA, Chapman AR: Practical and ethical considerations of noninvasive prenatal diagnosis. JAMA 2009; 301: 2154-2156.
3. Hall A, Bostanci A, Wright CF: Non-invasive prenatal diagnosis using cell-free fetal DNA technology: applications and implications. Public Health Genom 2010; 13: 246-255.
4. de Jong A, Dondorp WJ, de Die-Smulders CE, Frints SG, de Wert GM: Non-invasive prenatal testing: ethical issues explored. Eur J Hum Genet 2010; 18: 272-277.
5. Sayres LC, Allyse M, Norton ME, Cho MK: Cell-free fetal DNA testing: a pilot study of obstetric healthcare provider attitudes toward clinical implementation. Prenat Diagn 2011; 31: 1070-1076.
6. Kelly SE, Farrimond HR: Non-invasive preantal genetic testing: a study of public attitudes. Public Health Genom 2012; 15: 73-81.
7. Maliszewski KT: An Assessment of Genetic Counselors' Opinions on How Non-Invasive Prenatal Diagnosis may Impact Genetic Counseling Services. Waltham, MA: Brandeis University 2010 available online at https://bir.brandeis.edu/ handle/10192/24065 (accessed September 2012).
8. Kooij L, Tymstra T, Berg P, Kooij L, Tymstra T: Berg Pvd: the attitude of women toward current and future possibilities of diagnostic testing in maternal blood using fetal DNA. Prenat Diagn 2009; 29: 164-168.
9. Clinical Molecular Genetics Society (CMGS): Audit 2010-2011available from. http://wwwcmgsorg/CMGS%20audit/2011%20audit/CMGSAudit10-11-FINALpdf (accessed March 2012).
10. Metcalfe SA: Carrier screening in preconception consultation in primary care. J Community Genet 2012; 3: 193-203.
11. NHS Sickle Cell and Thalassaemia Standards for the Linked Antenatal and Newborn Screening Program 2011.
12. Chitty LS, Griffin DR, Meaney C et al: New aids for the non-invasive prenatal diagnosis of achondroplasia: dysmorphic features, charts of fetal size and molecular confirmation using cell-free fetal DNA in maternal plasma. Ultrasound Obstet Gynecol 2011; 37: 283-289.
13. Mujezinovic F, Alfirevic Z: Procedure-related complications of amniocentesis and chorionic villous sampling: a systematic review. Obstet Gynecol 2007; 110: 687-694.
14. Lo YM, Zhang J, Leung TN, Lau TK, Chang AM, Hjelm NM: Rapid clearance of fetal DNA from maternal plasma. Am J Hum Genet 1999; 64: 218-224.
15. Lau T, Leung T, Chan L et al: Fetal DNA clearance from maternal plasma is impaired in preeclampsia. Clin Chem 2002; 4: 2141-2146.
16. Lo YM, Tein MS, Lau TK et al: Quantitative analysis of fetal DNA in maternal plasma and serum: implications for noninvasive prenatal diagnosis. Am J Hum Genet 1998; 62: 768-775.
17. Hill M, Finning K, Martin P et al: Non-invasive prenatal determination of fetal sex: translating research into clinical practice. Clin Genet 2011; 80: 68-75.
18. Lun FM, Chiu RW, Allen Chan KC, Yeung Leung T, Kin Lau T, Dennis Lo YM: Microfluidics digital PCR reveals a higher than expected fraction of fetal DNA in maternal plasma. Clin Chem 2008; 54: 1664-1672.
19. Finning KM, Chitty LS: Non-invasive fetal sex determination: impact on clinical practice. Semin Fetal Neonatal Med 2008; 13: 69-75.
20. Lewis C, Hill M, Skirton H, Chitty L: Non-invasive prenatal diagnosis for fetal sexing-what is the value for service users? Eur J Hum Genet 2012; 20: 1127-1133.
21. Lewis C, Hill M, Skirton H, Chitty L: Fetal sex determination using free fetal DNA: service users' experiences and preferences for how the service should be offered in clinical practice. Prenat Diagn 2012; 32: 735-741.
22. Hill M, Taffinder S, Chitty LS, Morris S: Incremental cost of non-invasive prenatal diagnosis versus invasive prenatal diagnosis of fetal sex in England. Prenat Diagn 2011; 31: 267-273.
23. Raymond FL, Whittaker J, Jenkins L, Lench N, Chitty LS: Molecular prenatal diagnosis: the impact of modern technologies. Prenat Diagn 2010; 30: 674-681.
24. Meaney C, Norbury G: Noninvasive prenatal diagnosis of early onset primary dystonia I in maternal plasma. Prenat Diagn 2009; 29: 1218-1221.
25. Galbiati S, Brisci A, Lalatta F et al: Full COLD-PCR protocol for noninvasive prenatal diagnosis of genetic diseases. Clin Chem 2011; 57: 136-138.
26. Tsui NB, Kadir RA, Chan KC et al: Noninvasive prenatal diagnosis of hemophilia by microfluidics digital PCR analysis of maternal plasma DNA. Blood 2011; 117: 3684-3691.
27. Lun FM, Tsui NB, Chan KC et al: Noninvasive prenatal diagnosis of monogenic diseases by digital size selection and relative mutation dosage on DNA in maternal plasma. Proc Natl Acad Sci USA 2008; 105: 19920-19925.
28. Barrett AN, McDonnell T, Chitty LS: Digital PCR analysis of maternal plasma for non-invasive detection of sickle cell anaemia. Clin Chem 2012; 58: 1026-1032.
29. Lo Y, Chan K, Sun H et al: Maternal plasma DNA sequencing reveals the genome-wide genetic and mutational profile of the fetus. Sci Transl Med 2010; 2: 61ra91.
30. Bot-Robin V, Sendon S, Bourzoufi K et al: Maternal anxiety and pain during prenatal diagnostic techniques: a prospective study. Prenat Diagn 2012; 32: 562-568.
31. Berkenstadt M, Shiloh S, Barkai G, Katznelson MB, Goldman B: Perceived personal control (PPC): a new concept in measuring outcome of genetic counseling. Am J Med Genet 1999; 82: 53-59.
32. McAllister M, Payne K, Macleod R, Nicholls S, Dian D, Davies L: Patient empowerment in clinical genetics services. J Health Psychol 2008; 13: 895-905.
33. Skirton H: The client's perspective of genetic counselling-a grounded theory study. J Genet Couns 2001; 10: 311-329.
34. Sapp JC, Hull SC, Duffer S et al: Ambivalence toward undergoing invasive prenatal testing: an exploration of its origins. Prenat Diagn 2010; 30: 77-82.
35. Fan HC, Gu W, Wang J, Blumenfeld YJ, El-Sayed YY, Quake SR: Non-invasive prenatal measurement of the fetal genome. Nature 2012; 487: 320-324.
36. Hill M, Compton C, Lewis C, Skirton H, Chitty LS: Determination of foetal sex in pregnancies at risk of haemophilia: a qualitative study exploring the clinical practices and attitudes of health professionals in the United Kingdom. Haemophilia 2011; 18: 575-583.
37. O'Neil O: Autonomy and Trust in Bioethics. Cambridge: Cambridge University Press, 2002.
38. Beauchamp T, Childress J: Principles of Biomedical Ethics. Oxford: Oxford University Press, 2008.
39. Press N, Browner CH: Why women say yes to prenatal diagnosis. Soc Sci Med 1997; 45: 979-989.
40. Garcia E, Timmermans DR, van Leeuwen E: Rethinking autonomy in the context of prenatal screening decision-making. Prenat Diagn 2008; 28: 115-120.
41. Kelly SE: Choosing not to choose: reproductive responses of parents of children with genetic conditions or impairments. Sociol Health Illn 2009; 31: 81-97.
42. Seavilleklein V: Challenging the rhetoric of choice in prenatal screening. Bioethics 2009; 23: 68-77.
43. Marteau TM, Dormandy E, Michie S: A measure of informed choice. Health Expect 2001; 4: 99-108
44. van den Berg M, Timmermans DR, Ten Kate LP, van Vugt JM, van der Wal G: Are pregnant women making informed choices about prenatal screening? Genet Med 2005; 7: 332-338.
45. van den Heuvel A, Chitty L, Dormandy E et al: Will the introduction of non-invasive prenatal diagnostic testing erode informed choices? An experimental study of health care professionals. Patient Educ Couns 2010; 78: 24-28.
46. Henneman L, Bramsen I, van der Ploeg HM, ten Kate LP: Preconception cystic fibrosis carrier couple screening: impact, understanding, and satisfaction. Genet Test 2002; 6: 195-202.
47. Modell B, Darlison M: Global epidemiology of haemoglobin disorders and derived service indicators. Bull World Health Organ 2008; 86: 480-487.
48. Locock L, Kai J: Parents' experiences of universal screening for haemoglobin disorders: implications for practice in a new genetics era. Br J Gen Pract 2008; 58: 161-168.
49. Tsianakas V, Calnan M, Atkin K, Dormandy E, Marteau TM: Offering antenatal sickle cell and thalassaemia screening to pregnant women in primary care: a qualitative study of GPs' experiences. Br J Gen Pract 2010; 60: 822-828.
50. Tsianakas V, Atkin K, Calnan MW, Dormandy E, Marteau TM: Offering antenatal sickle cell and thalassaemia screening to pregnant women in primary care: a qualitative study of women's experiences and expectations of participation. Health Expect 2012; 15: 115-125.
51. Sherwin S: Normalizing reproductive technologies and the implications for autonomy; in: Tong R, Anderson G, Santos A (eds). Globalizing Feminist Bioethics. Boulder, CO: Westview Press, 2001; pp 96-113.
52. Favre R, Moutel G, Duchange N et al: What about informed consent in first-trimester ultrasound screening for Down syndrome? Fetal Diagn Ther 2008; 23: 173-184.
53. Nicol M: Vulnerability of first-time expectant mothers during ultrasound scans: an evaluation of the external pressures that influence the process of informed choice. Health Care Women Int 2007; 28: 525-533.
54. Rapp R: Testing Women, Testing the Fetus: The Social Impact of Amniocentesis in America. New York: Routledge, 1999.
55. Baillie C, Smith J, Hewison J, Mason G: Ultrasound screening for chromosomal abnormality: women's reactions to false positive results. Br J Health Psych 2000; 5: 377-394.
56. Heyman B, Hundt G, Sandall J et al: On being at higher risk: a qualitative study of prenatal screening for chromosomal anomalies. Soc Sci Med 2006; 62: 2360-2372.
57. Garcia J, Bricker L, Henderson J et al: Women's views of pregnancy ultrasound: a systematic review. Birth 2002; 29: 225-250.
58. Deans Z, Newson AJ: Should non-invasiveness change informed consent procedures for prenatal diagnosis? Health Care Anal 2011; 19: 122-132.
59. Dormandy E, Gulliford M, Bryan S et al: Effectiveness of earlier antenatal screening for sickle cell disease and thalassaemia in primary care: cluster randomised trial. BMJ 2010; 341: c5132
60. Paton v UK 3 EHRR 408 1981.
61. Chadwick R: The philosophy of the right to know and the right not to know; in: Chadwick R, Levitt M, Shickle D (eds). The Right to Know and the Right not to Know. Brookfield: Ashgate, 1997; pp 13-22.
62. Narveson J: The Libertarian Idea. Ontario: Broadview, 2001.
63. Sommerville A, English V: Genetic privacy: orthodoxy or oxymoron? J Med Ethics 1999; 25: 144-150.
64. Hodgson J, Spriggs M: A practical account of autonomy: why genetic counseling is especially well suited to the facilitation of informed autonomous decision making J Genet Couns 2005; 14: 89-97.
65. Bernhardt BA, Biesecker BB, Mastromarino CL: Goals, benefits, and outcomes of genetic counseling: client and genetic counselor assessment